Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioDFence G3 in Robotic-Assisted Radical Prostatectomy
NCT05363644Phase 3Withdrawn
- Sponsor
- AdventHealth
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of BioDFence G3 Placental Tissue Membrane in erectile dysfunction (ED), urinary incontinence (UI), sponsored by AdventHealth. Planned start Apr 2023; status: withdrawn.
02
Drugs
BioDFence G3 Placental Tissue Membrane
03
Conditions
erectile dysfunction (ED)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT05363644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05363644.